Before I get into this issue's deals and analysis, I want to tell you about two changes starting with this issue.
The first is a new section near the bottom called Other Deals. Behind the scenes, every in-scope deal we track gets a full analysis, and each issue features the handful with the strongest signals. Other Deals is where the rest show up, along with a few bigger rounds outside our early-stage focus, with one line each and a link to the original source, so that if an early-stage sports deal went public, you can find it here. Next year we're opening up the full database of those analyses as part of the CapSignal data platform, so you'll be able to dig into every deal, not only the ones that make the issue.
The second is that every company name now links to where the facts came from, because a number of you told me you wanted to be able to check our work, and now you can.
This issue covers early-stage deals announced or filed between Oct 1 and Oct 26 that weren't in Issue #14.
By the Numbers
21 new deals analyzed that surfaced in October.
About $32.8M in disclosed capital across the five deals featured below. That's those five only, not the market.
2 athlete-economy deals (Agentiq and Endo). In Issue #14 we logged zero.
11 of 21 named no clear lead investor.
Primary Signal: Agentiq
Agentiq raises $4M to sell fans a cut of athletes' future earnings. Three companies have tried versions of this before.
Athlete income is becoming a retail investment product, and the history of the idea is the best guide to whether it works this time.
What happened. Agentiq raised $4M on Oct 7, led by defy.vc, with an unnamed group led by the owner of two European football clubs. Defy also led the company's $1M pre-seed. The model: an athlete gets upfront cash and advisory help, and in return a separate LLC tied to that athlete gets a defined share of their future on-field income. Fans buy units in that LLC through SEC-qualified Reg A Tier 2 offerings. Five baseball players are signed, with a pipeline the company puts at more than 200 athletes.
Why it matters. This has been tried, and each attempt failed in a different place. Front Office Sports lays out the record:
Fantex signed NFL players including Vernon Davis and folded by 2016, partly because hardly anyone traded the shares. An arbitrator later ordered it to pay Mohamed Sanu about $1.15M.
Big League Advance paid Fernando Tatis Jr. $2M in 2017 for 10% of his future MLB earnings. He stopped paying in 2024, and a judge upheld an award of about $3.74M against him.
Finlete's highest-profile athlete, Emmanuel Clase, was indicted in an alleged pitch-rigging scheme.
Fantex ran out of buyers and sellers, Big League Advance had to fight to get paid, and Finlete had too much riding on one player. Agentiq's pitch is that the regulatory path is clearer now and the fintech is better. The founders also plan to let investors sell units to each other and to offer "baskets," single investments spread across several athletes. Those would answer two of the three problems. Neither exists yet. (We wrote up the full history here.)
The catch. The risk is already on the roster. Justin Martinez returned in August from his second Tommy John surgery. Hunter Dobbins had elbow reconstruction in early September with a 12-month recovery, per Tech Funding News. Fees stack up too: a 1% broker fee, a one-time negotiation fee of about 4% of gross proceeds, and 2.5% of every distribution. And as of the final offering circular on Sept 28, no units had been sold.
Capital structure notes.
Two separate things are being financed. The $4M is equity in Agentiq the company. The athlete offerings are separate LLC series, each sized on its own (Ronny Cruz's offering covers up to 12,900 units at $100, about $1.29M).
Investors own a share of defined income, not the athlete and not Agentiq.
Non-accredited investors are capped at 10% of the greater of their annual income or net worth. Distributions aren't guaranteed and there's no public market for the units.
For founders: Every athlete-finance company so far has been able to sign athletes. None has solved what happens after the money moves: pricing the asset, letting investors exit and collecting when an athlete stops paying. If you're building in the athlete economy, that's where the open problem sits.
What to watch. Reg A Tier 2 issuers file semiannual and annual reports with the SEC. Agentiq's first ones will show how many units each athlete series actually sold. That number will tell us more than any launch announcement.
Secondary Signals
Endo: C$815K pre-seed (~US$573K)
Someone is building the pricing tool the athlete economy is missing.
Round: C$815K pre-seed on SAFEs, closed in July, announced Oct 7
Backers: Relay Ventures (lead) and unnamed angels
What it does: Endo sells sports agencies software for rosters, contracts, payments and deliverables. Its endodeals tool values endorsement offers using media-equivalency data and anonymized comparable contracts. It launched with 11 agency customers, including Quartexx Management and Roy Sports Group.
Our read: Read it next to Agentiq. One company wants fans to buy a slice of athlete income, and the other is building a way to say what that income is worth. The founder says NIL deals are next. The valuation tool only works if agencies trust its comparables, and that takes data most agencies have never shared.
Rezzil: $10M growth round (£7.5M reported)
The cap table is the pitch: Jobe Bellingham, Thierry Henry, Vincent Kompany and the Premier League.
Round: $10M strategic growth funding, announced Oct 19
Backers: Jobe Bellingham (reported lead) and Phil Kenyon, with the Premier League continuing its backing. Henry, Kompany and Cesc Fàbregas are among its investors.
What it does: Rezzil turns player and ball movement into data for training, broadcast analysis and games. The money funds offices in London and Chicago and a push into consumer mobile games.
Our read: This is a growth round, outside our usual stage range, and it's here because of who wrote the checks. Athlete money isn't new in our coverage. MLB veterans backed NurivaTech in Issue #5, and Hansi Flick and Julian Draxler joined Coachbetter's round in Issue #7. What's new is an active player reported as the lead. The open question is the consumer games bet, which is a very different business from selling to clubs.
International Dance League: $15M Series A
A brand-new league is raising like a media company, and the second check came from the same lead.
Round: $15M Series A, announced Oct 21
Backers: Elysian Park Ventures (lead, also led the $7M seed last November), with Sony, KB Partners, APEX, Yamaha Music Innovations Fund and October Ventures
What it does: IDL runs a season-long competition between six international dance teams. It reports six sold-out events, 2 billion social views and an ESPN2 rights deal from its first season.
Our read: In Issue #2, Kings League showed that investors will pay for a league built around how people watch online. IDL tests the same idea with a sport most investors never thought of as one. The catch is that views aren't revenue, no revenue has been disclosed, and international touring gets expensive fast.
Collective X Health: $3.2M pre-seed
The women's sports boom needs better data underneath it, and two paying customers say so.
Round: $3.2M oversubscribed pre-seed, announced Oct 13
Backers: Council Capital and Anthemis Female Innovators Lab Fund (co-leads), with SoGal, Emerson Collective, Muse and Segal
What it does: Collective X Health licenses peer-reviewed, female-specific health and performance research to brands through an API. Human Powered Health and Altra Running are founding customers, and per Forbes the company launched with paying customers rather than pilots.
Our read: We've tracked performance-data rounds before, from Hexis's nutrition software in Issue #9 to Biolyz's saliva testing in Issue #12. Collective X backs the research those products depend on, specifically for women. The bet only works if brands keep paying to license that research instead of building it in-house.
Fast Scan
Prediction and fantasy
CRSHMARKET, $3.5M seed led by 6th Man Ventures. Prediction markets on livestreams that settle in 60 seconds. Prediction markets have run through this newsletter since Pred in #3, and this one bets on streams instead of games. The founder reports $10M in trading volume in five months, a company figure worth checking.
GetPicks, $3M seed from unnamed gaming operators. Daily fantasy with social lineup copying and fast payouts. It reports 35,000 registered users in 21 states, but registered isn't active.
Venues and club software
SPASH, €2M Series A (~$2.2M). Cameras and software in nearly 450 padel, tennis and five-a-side centers that give amateurs highlights and stats. Same instrumented-court idea as Zenniz in #3, aimed at amateurs instead of tennis clubs.
Huppa, €1M pre-seed (~$1.12M). All-in-one software for class-based gyms in the Netherlands and Belgium. Second gym-software round in two issues after 1club in #14, and both are pitching one system to replace a pile of tools.
swimbooker, undisclosed six-figure check from Watchfinder co-founder Stuart Hennell. Booking and payments for UK fishing venues, with 140,000 registered anglers. The money goes to its first national TV campaign.
Training formats and games
XENOM, undisclosed strategic investment from HYROX co-founders Christian Toetzke and Moritz Fürste, who join the board. The biggest fitness-race brand is backing a would-be rival format instead of competing with it. We first tracked HYROX-era money with Roxfit in #4.
All-Time Studios, undisclosed strategic investment from agency Athletes First. The Israeli studio behind 82-0 is launching a football follow-up. An agency investing its client access instead of just licensing it is a deal structure to watch.
Other Deals
The rest of October: deals we analyzed but didn't feature, plus bigger rounds outside our early-stage focus. One line each, linked to the source.
Growth and later-stage
Pro Shop, $24M Series B led by Arthur Blank's family office. The golf media company behind Netflix's Full Swing is putting the money into live events.
Wiremind, €35M (~$39.2M), its first outside round after more than a decade self-funded. Sports ticketing is one product line inside a mostly transport business, so don't count all of it as sports money.
New pools of capital
32 Equity and General Atlantic, a joint venture approved by NFL owners Oct 20. The league's roughly $250M investment arm now has a $130B private equity partner. Fund size wasn't disclosed.
Engyne Health, undisclosed angel round with Humphrey Cobbold among the named investors. Amount and stage not disclosed.
Filings worth a look
Juice Reel, $2.5M from 17 unnamed investors (Form D, Oct 19). The bettor-analytics app went live with a ProphetX integration on Oct 14.
Park Golf, $700K of $2M for a pitch-and-putt venue planned for San Antonio.
Play Your Court, $120K SAFE for an app that books independent tennis coaches.
Too early to call
Maincard, $7M from unnamed iGaming backers to expand a white-label betting platform in the US. Its own legal page lists the US as a prohibited jurisdiction, so we're waiting on details.
IDA Sports, $3M reported, led by CoverFour. The SEC filing shows $2.1M sold, so we'll wait for the numbers to line up.
The Big Leagues, £500K (~$662K) for UK sports prize draws paired with free prediction games. Raised over the summer and disclosed this month, investors undisclosed.
Market Signals
1. Athletes showed up on every side of the deal
Agentiq turns athletes into the asset. Endo, founded by a former athlete, prices them for their agents. At Rezzil, a current player is reported as lead investor and the cap table is full of former pros. Athletes First put agency money into a game studio. In October, athletes were the product, the pricing problem and the lead check.
For founders: If an athlete is on your cap table, ask what they bring beyond the logo. In these deals the value was distribution (Athletes First), credibility with clubs (Rezzil) or access to deal data (Endo).
2. Prediction money moved from the plumbing to the front door
Issue #14 logged a record four prediction-market infrastructure deals in one month. October brought six betting, fantasy and prediction deals, and only one, CRSHMARKET, has a confirmed institutional lead. The rest are smaller consumer apps funded by angels, operators or investors no one named. One possible read: the infrastructure got funded first, and consumer apps are now raising cheaper money to build on top of it.
3. Half of October's deals didn't name a lead
Eleven of the 21 deals we analyzed this month named no clear lead investor, and three surfaced only through SEC Form D filings. Much of early-stage sports money is angels, operators and unnamed backers. That's normal at this stage, but it means a round with a named, credible lead now stands out more than the dollar amount does.
What didn't show up
No team or club ownership deals in October's set. IDL is the only league, and it raised venture money as a new company rather than selling a stake in an established property.
Final Whistle
Here's my prediction. When Agentiq files its first report on how many units it sold, the product that matters won't be any single player. It'll be the baskets, where one investment is spread across several athletes. Fans love players, but investors don't want their money riding on one elbow. Agentiq's model has a real shot if it gets baskets live before injuries start showing up in the distributions.
Building CapSignal: This is the first issue with Other Deals and source links on every company. Next we're building the searchable database of every deal we've analyzed, planned for 2027. If a section isn't earning its space, reply and tell me.
Maayan Gordon
Founder, CapSignal Sports
